Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients "B-CAUSE"


Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to document the effectiveness of treating chronic post-stroke spastic patients with Botulinum Toxin type A.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 September 2017.

1 Jun 2015 4 Mar 2015 28 Aug 2017 28 Aug 2017 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample